| | January | February | March | April | May | June | July | August | September | October | November | December |
|---|
| ACSM | | | | | | | | | | | | |
|---|
| Childhood TB | | | | | | | | | | | | |
|---|
| Community-based activities for improved TB prevention, diagnosis | | | | | | | | | | | | |
|---|
| Cross-cutting Health System Strengthening | | | | | | | | | | | | |
|---|
| Drug and commodities management | | | | | | | | | | | | |
|---|
| Drug Resistance Surveillance (DRS) | | | | | | | | | | | | |
|---|
| Global Fund grant implementation | | | | | | | | | | | | |
|---|
| Global Fund grant negotiation | | | | | | | | | | | | |
|---|
| Global Fund Processes | | | | | | | | | | | | |
|---|
| Global Fund proposal development | | | | | | | | | | | | |
|---|
| High risk groups: prisoners, refugees, TB contacts, special | | | | | | | | | | | | |
|---|
| Human Resources Development | | | | | | | | | | | | |
|---|
| Infection control | | | | | | | | | | | | |
|---|
| Laboratory strengthening | | | | | | | | | | | | |
|---|
| M&E/supervision/ impact measurement | | | | | | | | | | | | |
|---|
| MDR-TB / XDR-TB | | | | | | | | | | | | |
|---|
| Operational and basic science research | | | | | | | | | | | | |
|---|
| Other | | | | | | | | | | | | |
|---|
| PAL | | | | | | | | | | | | |
|---|
| Partnering | | | | | | | | | | | | |
|---|
| PPM, ISTC | | | | | | | | | | | | |
|---|
| TB programme planning and review / regional meetings | | | | | | | | | | | | |
|---|
| TB/HIV | | | | | | | | | | | | |
|---|
| X-ray, other non-laboratory diagnostics | | | | | | | | | | | | |
|---|
|
|
